Needham Remains Positively Inclined Toward FDA CBER Approval for Dendreon (DNDN) Provenge
Tweet Send to a Friend
Needham issued a note on Dendreon Corp. (Nasdaq: DNDN) with about two week unitl the PDUFA on Provenge. The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


